Literature DB >> 9139981

Temporal effects of cytokines on neonatal cardiac myocyte Ca2+ transients and adenylate cyclase activity.

R J Bick1, J P Liao, T W King, A LeMaistre, J B McMillin, L M Buja.   

Abstract

This study investigates the hypothesis that inflammatory cytokines, interleukin (IL)-1alpha IL-1beta, and tumor necrosis factor (TNF), influence cardiac function by affecting calcium homeostasis and that this effect is mediated by the beta-adrenergic-adenylate cyclase system. After 4 days in culture, neonatal rat ventricular myocytes were treated with cytokines (10 ng/ml) for short (2 h) or longer (18 h) times. Myocyte calcium, contractility, and adenylate cyclase were measured under each condition. Anticipated stepwise increases in adenylate cyclase and intracellular calcium were found in controls (non-cytokine-treated) with 10(-7) M isoproterenol, 10(-7) M isoproterenol + 0.1 mM guanosine triphosphate, and 10(-9) M forskolin. Cells in the presence of cytokine for 2 h show increased basal calcium levels but no changes in adenylate cyclase activities, and isoproterenol fails to elevate adenylate cyclase levels or affect contractile shortening. After long-term treatment with IL-1beta or TNF, but not IL-1alpha, the significantly elevated levels of basal systolic calcium remain, and isoproterenol increases adenylate cyclase activity, unlike after short exposure. Forskolin maximally activates adenylate cyclase following both short- and long-term incubation, but the stepwise increase in activity is blunted following prolonged exposure. Thus short-term cytokine treatment blocks the adrenergic receptor-mediated increases in adenosine 3',5'-cyclic monophosphate, dissociating adenylate cyclase activation from cytokine-mediated increases in cell calcium, whereas longer treatment apparently produces direct affects on adenylate cyclase. Time-dependent differences in contractile response were found with IL-1alpha at 2 h and TNF at 18 h, implying that myofibrillar responsiveness to increased cytoplasmic calcium is dependent on both cytokine species and exposure time.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139981     DOI: 10.1152/ajpheart.1997.272.4.H1937

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  The role of interleukin-1 in the failing heart.

Authors:  C S Long
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitro.

Authors:  Ion A Hobai; Justin C Morse; Deborah A Siwik; Wilson S Colucci
Journal:  J Surg Res       Date:  2014-09-22       Impact factor: 2.192

4.  Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy.

Authors:  Elena Westphal; Susanne Rohrbach; Michael Buerke; Hagen Behr; Dorothea Darmer; Rolf-Edgar Silber; Karl Werdan; Harald Loppnow
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

Review 5.  Proinflammatory Cytokines Mediate GPCR Dysfunction.

Authors:  Maradumane L Mohan; Neelakantan T Vasudevan; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2017-08       Impact factor: 3.105

6.  A novel signaling mechanism between gas and blood compartments of the lung.

Authors:  W M Kuebler; K Parthasarathi; P M Wang; J Bhattacharya
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 7.  The physiology of cardiovascular disease and innovative liposomal platforms for therapy.

Authors:  Guillermo U Ruiz-Esparza; Jose H Flores-Arredondo; Victor Segura-Ibarra; Guillermo Torre-Amione; Mauro Ferrari; Elvin Blanco; Rita E Serda
Journal:  Int J Nanomedicine       Date:  2013-02-09

8.  Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia.

Authors:  P Costelli; R De Tullio; F M Baccino; E Melloni
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

9.  Olfactory Dysfunction in Patients with Ischemic Heart Failure.

Authors:  Ercan Akşıt; Özge Çağlar Çıl
Journal:  Acta Cardiol Sin       Date:  2020-03       Impact factor: 2.672

10.  Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure.

Authors:  Almudena Val-Blasco; Jose A Navarro-García; Maria Tamayo; Maria J Piedras; Patricia Prieto; Carmen Delgado; Gema Ruiz-Hurtado; Laura Rozas-Romero; Marta Gil-Fernández; Carlos Zaragoza; Lisardo Boscá; María Fernández-Velasco
Journal:  Front Physiol       Date:  2018-06-14       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.